Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer-Reply
JAMA Oncol
.
2020 Jun 1;6(6):934-935.
doi: 10.1001/jamaoncol.2020.0292.
Authors
Mahdi Fallah
1
,
Trasias Mukama
1
,
Elham Kharazmi
1
Affiliation
1
Risk Adapted Prevention Group, Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
PMID:
32379279
DOI:
10.1001/jamaoncol.2020.0292
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / diagnosis
Breast Neoplasms* / epidemiology
Breast Neoplasms* / genetics
Early Detection of Cancer
Humans
Mammography
Mass Screening